CAS 1252765-13-1

JNJ-42226314

CAS : 1252765-13-1

JNJ-42226314

Degré de pureté : ≥98%

Masse moléculaire : 489.56g/mol

Ref: 54-BUP09558

Compound 6g

CAS : 1252765-13-1

Compound 6g is a heterocyclic compound that has been studied for its potential use as an anticancer agent. It has been shown to have a significant cytotoxicity in the plate test and it inhibits cell proliferation in human HL-60 cells. Compound 6g also inhibits the production of inflammatory cytokines, such as TNF-α, IL-1β, and IL-8 by inhibiting the activation of toll-like receptor 4 (TLR4). This molecule also shows inhibitory properties on various biological processes including mitochondrial membrane potential, inhibitor binding, and protein synthesis. Molecular docking analysis has shown that Compound 6g binds to the ATP binding site of bacterial DNA gyrase.

Formule : C₂₆H₂₄FN₅O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 489.16347

Ref: 3D-BC178099

JNJ-42226314

CAS : 1252765-13-1

JNJ-42226314 is a MAGL inhibitor with anti-injury effects and has shown efficacy in neuropathic pain and inflammatory pain models.

Formule : C₂₆H₂₄FN₅O₂S

Degré de pureté : 99.62%

Couleur et forme : Solid

Masse moléculaire : 489.56

Ref: TM-T11724